Showing results (51-60 of 418) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Peptide and dendritic cell vaccinesCraig L Slingluff, Victor H Engelhard, Soldano Ferrone
Trends in Cancer|September 7, 2021
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapyLuke Maggs, Ananthan Sadagopan, Ali Sanjari Moghaddam, et al.
Trends in Molecular Medicine|November 7, 2008
The complex role of B7 molecules in tumor immunologyBarbara Seliger, Francesco M Marincola, Soldano Ferrone, et al.
Cellular and Molecular Life Sciences : CMLS|November 11, 2010
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Laurence Amiot, Soldano Ferrone, Hans Grosse-Wilde, et al.
Journal of the American Academy of Dermatology|March 27, 2012
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?Michael Campoli, James E Fitzpatrick, Whitney High, et al.
Seminars in Cancer Biology|September 28, 2018
The role of cancer stem cells in the modulation of anti-tumor immune responsesCristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, et al.
Oncology Research|February 24, 2015
Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blastsMoon Fenton, Theresa L Whiteside, Soldano Ferrone, et al.
Cancers|April 30, 2021
Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAsSara Tomei, Ola Ibnaof, Shilpa Ravindran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cellsTheresa L Whiteside, Joanna Stanson, Michael R Shurin, et al.
JAMA Oncology|December 23, 2021
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors: A ReviewAnanthan Sadagopan, Theodoros Michelakos, Gabriella Boyiadzis, et al.
Pageof 42